Barclays
ASTX

Barclays’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Barclays’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-168,900
Closed -$1.35M – 7970
2013
Q3 		$1.35M Buy
168,900
+130,300
+338% +$825K ﹤0.01% 3026
2013
Q2 		$159K Buy
+38,600
New +$208K ﹤0.01% 5403

Barclays's ASTX Position: Q4 2013 in Review

Barclays sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 1,770,479 shares — an estimated $14.2M sold.

Barclays first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $14.2M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Barclays reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Barclays sold 1,770,479 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $14.2M.
  • Barclays first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Barclays's ASTEX PHARMACEUTICALS, INC COM position peaked at $14.2M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.